UBS analyst Joshua Spector maintained a Buy rating on DuPont de Nemours today and set a price target of $91.00.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Joshua Spector has given his Buy rating due to a combination of factors related to DuPont de Nemours’ strategic moves and financial outlook. The upcoming spin-off of its electronics business, Qnity, is expected to unlock significant value for shareholders, as the separation will allow both entities to focus on their core operations and growth opportunities. Spector highlights that the remaining DuPont, post-spin, is trading at a valuation that appears undervalued compared to its potential, especially given its strong execution over the past 18 months and the attractive growth prospects in its industrial and materials segments.
Moreover, the financial metrics post-spin suggest a favorable position for DuPont. The company’s leverage is expected to be low, with a net debt to EBITDA ratio of approximately 1.0x, which could further decrease following the completion of the Aramids business sale. This low leverage, combined with projected sales and EBITDA growth, positions DuPont for potential valuation improvements. Spector sees these factors as indicative of a compelling investment opportunity, warranting the Buy rating.
According to TipRanks, Spector is a 3-star analyst with an average return of 1.5% and a 51.75% success rate. Spector covers the Basic Materials sector, focusing on stocks such as DuPont de Nemours, Albemarle, and Sherwin-Williams Company.
In another report released today, Wells Fargo also resumed coverage with a Buy rating on the stock with a $100.00 price target.